Neuroleptic malignant syndrome

Prachi Mehndiratta, Yonatan Spolter, Blessing Igboeli, Martha Sajatovic, Peter F. Buckley

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Neuroleptic malignant syndrome (NMS) is usually a serious neurologic side effect of antipsychotic therapy and characterized by fever, altered mental state, muscular rigidity, and dysautonomia. This chapter provides a contemporary account of NMS, a synthesis of a voluminous and perplexing literature on its pathobiology and management, and gives clear guidelines on the care and prognosis thereafter for patients who develop NMS.

Original languageEnglish (US)
Title of host publicationNeuromuscular Disorders in Clinical Practice
PublisherSpringer New York
Pages1487-1500
Number of pages14
Volume9781461465676
ISBN (Electronic)9781461465676
ISBN (Print)1461465664, 9781461465669
DOIs
StatePublished - Nov 1 2014

Fingerprint

Neuroleptic Malignant Syndrome
Primary Dysautonomias
Muscle Rigidity
Induced Hyperthermia
Nervous System
Antipsychotic Agents
Guidelines

Keywords

  • Neuroleptic malignant syndrome
  • antipsychotics
  • neuroleptics
  • serotonin syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mehndiratta, P., Spolter, Y., Igboeli, B., Sajatovic, M., & Buckley, P. F. (2014). Neuroleptic malignant syndrome. In Neuromuscular Disorders in Clinical Practice (Vol. 9781461465676, pp. 1487-1500). Springer New York. https://doi.org/10.1007/978-1-4614-6567-6_74

Neuroleptic malignant syndrome. / Mehndiratta, Prachi; Spolter, Yonatan; Igboeli, Blessing; Sajatovic, Martha; Buckley, Peter F.

Neuromuscular Disorders in Clinical Practice. Vol. 9781461465676 Springer New York, 2014. p. 1487-1500.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mehndiratta, P, Spolter, Y, Igboeli, B, Sajatovic, M & Buckley, PF 2014, Neuroleptic malignant syndrome. in Neuromuscular Disorders in Clinical Practice. vol. 9781461465676, Springer New York, pp. 1487-1500. https://doi.org/10.1007/978-1-4614-6567-6_74
Mehndiratta P, Spolter Y, Igboeli B, Sajatovic M, Buckley PF. Neuroleptic malignant syndrome. In Neuromuscular Disorders in Clinical Practice. Vol. 9781461465676. Springer New York. 2014. p. 1487-1500 https://doi.org/10.1007/978-1-4614-6567-6_74
Mehndiratta, Prachi ; Spolter, Yonatan ; Igboeli, Blessing ; Sajatovic, Martha ; Buckley, Peter F. / Neuroleptic malignant syndrome. Neuromuscular Disorders in Clinical Practice. Vol. 9781461465676 Springer New York, 2014. pp. 1487-1500
@inbook{3355ccf824824bac97453cf1ed60c048,
title = "Neuroleptic malignant syndrome",
abstract = "Neuroleptic malignant syndrome (NMS) is usually a serious neurologic side effect of antipsychotic therapy and characterized by fever, altered mental state, muscular rigidity, and dysautonomia. This chapter provides a contemporary account of NMS, a synthesis of a voluminous and perplexing literature on its pathobiology and management, and gives clear guidelines on the care and prognosis thereafter for patients who develop NMS.",
keywords = "Neuroleptic malignant syndrome, antipsychotics, neuroleptics, serotonin syndrome",
author = "Prachi Mehndiratta and Yonatan Spolter and Blessing Igboeli and Martha Sajatovic and Buckley, {Peter F.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1007/978-1-4614-6567-6_74",
language = "English (US)",
isbn = "1461465664",
volume = "9781461465676",
pages = "1487--1500",
booktitle = "Neuromuscular Disorders in Clinical Practice",
publisher = "Springer New York",

}

TY - CHAP

T1 - Neuroleptic malignant syndrome

AU - Mehndiratta, Prachi

AU - Spolter, Yonatan

AU - Igboeli, Blessing

AU - Sajatovic, Martha

AU - Buckley, Peter F.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Neuroleptic malignant syndrome (NMS) is usually a serious neurologic side effect of antipsychotic therapy and characterized by fever, altered mental state, muscular rigidity, and dysautonomia. This chapter provides a contemporary account of NMS, a synthesis of a voluminous and perplexing literature on its pathobiology and management, and gives clear guidelines on the care and prognosis thereafter for patients who develop NMS.

AB - Neuroleptic malignant syndrome (NMS) is usually a serious neurologic side effect of antipsychotic therapy and characterized by fever, altered mental state, muscular rigidity, and dysautonomia. This chapter provides a contemporary account of NMS, a synthesis of a voluminous and perplexing literature on its pathobiology and management, and gives clear guidelines on the care and prognosis thereafter for patients who develop NMS.

KW - Neuroleptic malignant syndrome

KW - antipsychotics

KW - neuroleptics

KW - serotonin syndrome

UR - http://www.scopus.com/inward/record.url?scp=84949175730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949175730&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6567-6_74

DO - 10.1007/978-1-4614-6567-6_74

M3 - Chapter

AN - SCOPUS:84949175730

SN - 1461465664

SN - 9781461465669

VL - 9781461465676

SP - 1487

EP - 1500

BT - Neuromuscular Disorders in Clinical Practice

PB - Springer New York

ER -